Docwire News

Here are the top stories covered by DocWire News this week in the Rheumatology section. In this edition, read about the Supreme Court’s stance on hundreds of lawsuits against pharmaceutical giant Merck, the latest Food and Drug Administration (FDA) approval for a plaque psoriasis treatment for adolescent patients, the long-term safety of secukinumab, and how opioids may affect outcomes in joint arthroplasty patients.

Here are the top stories covered by DocWire News this week in the Homepage section. This week’s edition discusses a large-scale study that linked rare DNA alterations to type 2 diabetes, how the use of cannabidiol can help treat heroin abusers, a brain-based method for diagnosing autism, and how the consumption of sugary beverages correlates to increased mortality.

Recent work from the University of Cambridge has found that virtual reality (VR) could be more effective in detecting early Alzheimer’s disease than traditional...

Acute Kidney Injury Study Examines Risk Factors for Neonatal AKI Clinical Journal of the American Society of Nephrology. 2019;14(2):183-195 Poor short- and long-term outcomes are associated with...

Use of nonsteroidal anti-inflammatory drugs (NSAIDs) in the United States in both prescription and over-the-counter forms is widespread; more than 70 million prescriptions for...

In patients with end-stage renal disease (ESRD), including children and adults, cardiovascular disease (CVD) is a leading cause of morbidity and mortality. In individuals...

There is a small but growing movement to create formal primary care nurse practitioner (NP) residency programs, similar to those for physicians, where the...